Elevated IL-6 Levels Linked To Increased Risk For Obesity-Related Cancers Among Patients With Type 2 Diabetes, Study Finds

September 04, 2024

Endocrinology Advisor (9/3, Eck) reports, “Elevated interleukin-6 (IL-6) levels are associated with an increased risk for obesity-related cancers among patients recently diagnosed with type 2 diabetes, according to study results.” The investigators “found no link between” tumor necrosis factor-alpha or high-sensitivity C-reactive protein “and obesity-related cancer risk.” The findings will be presented at the 60th Annual Meeting of the European Association for the Study of Diabetes.
PrevNext
January 2025
SuMoTuWeThFrSa
   1234
567891011
12131415161718
19202122232425
262728293031